Katherine Reedy, M.B.A

Katherine Reedy, M.B.A

Senior Vice President, Commercial

Katherine Reedy is Senior Vice President of Commercial of Castle Creek Biosciences, Inc.  As a senior commercial leader with nearly 20 years of experience in specialty pharmaceuticals, biotechnology and rare disease, Ms. Reedy’s expertise spans U.S. and global roles in sales, sales management, training, operations, marketing and strategy. 

Before joining Castle Creek, Ms. Reedy served as Vice President of Marketing and Business Analytics, working in rare blood cancers for PharmaEssentia.  Previously, she was responsible for building and operationalizing the go-to-market strategy and marketing infrastructure foundational to the most successful U.S. launch at Alexion to-date—Soliris, for patients with AchR+ generalized myasthenia gravis (gMG).  As a result, Ms. Reedy was hand-selected to spend nearly a year in Germany, re-focusing and prioritizing the Soliris neurology strategic initiatives for gMG and Neuromyelitis Optica Spectrum Disorder (NMOSD).

Earlier in her career, Ms. Reedy was the Group Marketing Director at Mallinckrodt for rare neurology therapeutics and pain care, and also spent nearly a decade at Cephalon (now Teva). She started her career at Eli Lilly following graduation from Southern Methodist University, where she was recognized as the Most Outstanding Student in the Cox School of Business. Ms. Reedy earned her M.B.A. from Texas Christian University.